Screener
Assembly Biosciences ASMB Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Assembly Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211987
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 214 | 221 |
| Operating lease right-of-use (ROU) assets | 2,369 | 2,508 |
| Other assets | 312 | 312 |
| Total assets | $235,508 | $257,590 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable | $1,129 | $1,171 |
| Accrued research and development expenses | 1,538 | 2,387 |
Item 1. Financial Statements
FAQ
- What is Assembly Biosciences's total assets?
- Assembly Biosciences (ASMB) reported total assets of $235.51M in Q1 2026.
- How has Assembly Biosciences's total assets changed year-over-year?
- Assembly Biosciences's total assets increased by 137.8% year-over-year, from $99.02M to $235.51M.
- What is the long-term trend for Assembly Biosciences's total assets?
- Over 5 years (2020 to 2025), Assembly Biosciences's total assets has grown at a -1.9% compound annual growth rate (CAGR), from $283.25M to $257.59M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Assembly Biosciences's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude